Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -95.97% | -2.47% | 87.47% | -61.10% | 165.02% |
| Total Depreciation and Amortization | 615.61% | -14.62% | -15.74% | -19.94% | -20.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.61% | 143.48% | -354.82% | 105.28% | -943.81% |
| Change in Net Operating Assets | -112.75% | 1,421.50% | -233.36% | -51.85% | 134.34% |
| Cash from Operations | -66.47% | 111.30% | -47.82% | 77.00% | 41.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -265.52% | -38.10% | -12.00% | -50.00% | 9.38% |
| Issuance of Common Stock | -92.54% | -27.27% | 63.49% | 335.56% | 509.09% |
| Repurchase of Common Stock | 100.00% | 100.00% | -144.44% | -2,340.67% | 53.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 146,418.52% | 97.93% | -197.06% | -2,528.19% | 90.72% |
| Foreign Exchange rate Adjustments | 126.53% | -199.52% | -327.50% | 124.18% | 64.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -769.10% | 106.22% | -53.04% | -266.37% | 74.92% |
